These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
578 related items for PubMed ID: 16344097
1. Treatment paradigms for the newly diagnosed patient with multiple myeloma. Greipp P. Semin Hematol; 2005 Oct; 42(4 Suppl 4):S16-21. PubMed ID: 16344097 [Abstract] [Full Text] [Related]
3. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial. Kim HJ, Yoon SS, Lee DS, Sohn SK, Eom HS, Lee JL, Chung JS, Kim K, Suh C, Won JH, Kim JS, Park JS, Kang HJ, Seong CM, Kim CS, Lee SJ, Lee JH. Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621 [Abstract] [Full Text] [Related]
4. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma. Laubach JP, Schlossman RL, Mitsiades CS, Anderson KC, Richardson PG. Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778 [Abstract] [Full Text] [Related]
5. New drugs for myeloma. Richardson PG, Mitsiades C, Schlossman R, Munshi N, Anderson K. Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058 [Abstract] [Full Text] [Related]
6. Initial therapy in multiple myeloma: investigating the new treatment paradigm. Kettle JK, Finkbiner KL, Klenke SE, Baker RD, Henry DW, Williams CB. J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138 [Abstract] [Full Text] [Related]
10. Novel agents in myeloma: an exciting saga. Mark T, Niesvizky R, Coleman M. Cancer; 2009 Jan 15; 115(2):236-42. PubMed ID: 19025986 [No Abstract] [Full Text] [Related]
11. Treatment of multiple myeloma in the targeted therapy era. Saad AA, Sharma M, Higa GM. Ann Pharmacother; 2009 Feb 15; 43(2):329-38. PubMed ID: 19193585 [Abstract] [Full Text] [Related]
15. [Multiple myeloma -- therapy]. Jung W, Zettl F, Schroers R. Dtsch Med Wochenschr; 2005 Feb 11; 130(6):283-6; quiz 287-90. PubMed ID: 15692903 [No Abstract] [Full Text] [Related]
16. Novel therapies in myeloma. Hayden PJ, Mitsiades CS, Anderson KC, Richardson PG. Curr Opin Hematol; 2007 Nov 11; 14(6):609-15. PubMed ID: 17898564 [Abstract] [Full Text] [Related]
17. [New treatment strategy of multiple myeloma for cure]. Murakami H, Handa H. Gan To Kagaku Ryoho; 2006 Apr 11; 33(4):417-23. PubMed ID: 16612147 [Abstract] [Full Text] [Related]
18. Lenalidomide and thalidomide: mechanisms of action--similarities and differences. Anderson KC. Semin Hematol; 2005 Oct 11; 42(4 Suppl 4):S3-8. PubMed ID: 16344099 [Abstract] [Full Text] [Related]
19. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience. Zheng W, Wei G, Ye X, He J, Li L, Wu W, Shi J, Zhang J, Huang W, Xie W, Luo Y, Xue X, Lin M, Huang H, Cai Z. Leuk Res; 2009 Dec 11; 33(12):1615-8. PubMed ID: 19773080 [Abstract] [Full Text] [Related]
20. Management of older patients with multiple myeloma. Gay F, Palumbo A. Blood Rev; 2011 Mar 11; 25(2):65-73. PubMed ID: 21295387 [Abstract] [Full Text] [Related] Page: [Next] [New Search]